Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N03CB)1
- Citation:
- Cancer vol 113 (4) 847-853
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- U10 CA035267, U10 CA037417, K24 CA131099, N01 CA035431, U10 CA035269, CA-37404, CA-35090, CA-35195, U10 CA037404, U10 CA063848, U10 CA035195, CA-35103, CA-25224, CA-35113, U10 CA035101, U10 CA035113, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, CA-37417, CA-35269, CA-35101, U10 CA025224, U10 CA035090, CA-35267, CA-63849, U10 CA035103
- Corr. Author:
- Authors:
- Aminah Jatoi Kendrith Rowland Jeff A. Sloan Howard M. Gross Paul A. Fishkin Stephen P. Kahanic Paul J. Novotny Paul L. Schaefer David B. Johnson Loren K. Tschetter Charles L. Loprinzi
- Networks:
- Study
- NCCTG-N03CB
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Article